Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 117 Pages
Report ld: 5342971
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Fusion Transcript Assays Market Size(US$)
CAGR 2025-2031
3.6%
Market Size,2031
USD 119
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 96 million
Market Forecast in 2031(Value)
US$ 119 million
CAGR
3.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Fusion Transcript Assays market is projected to grow from US$ 93 million in 2024 to US$ 119 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Fusion Transcript Assays leading manufacturers including Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, Hologic Inc., Hologic Inc Bio-Rad Laboratories Inc., Caris Life Sciences, SeraCare Life Sciences Inc., QIAGEN, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Fusion Transcript Assays market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Illumina, Inc.
- Merck Millipore
- Hologic Inc.
- Hologic Inc Bio-Rad Laboratories Inc.
- Caris Life Sciences
- SeraCare Life Sciences Inc.
- QIAGEN
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fusion Transcript Kits
- PCR Devices
Segment by Application
- Hospital
- Cancer Research Center
- Diagnostic Laboratory
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Fusion Transcript Assays study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Fusion Transcript Assays: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fusion Transcript Assays Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Fusion Transcript Kits
1.2.3 PCR Devices
1.3 Market Segmentation by Application
1.3.1 Global Fusion Transcript Assays Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Cancer Research Center
1.3.4 Diagnostic Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fusion Transcript Assays Revenue Estimates and Forecasts 2020-2031
2.2 Global Fusion Transcript Assays Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Fusion Transcript Assays Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Fusion Transcript Assays Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Fusion Transcript Kits Market Size by Players
3.3.2 PCR Devices Market Size by Players
3.4 Global Fusion Transcript Assays Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Fusion Transcript Assays Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Fusion Transcript Assays Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Fusion Transcript Assays Market Size by Type (2020-2031)
6.4 North America Fusion Transcript Assays Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Fusion Transcript Assays Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Fusion Transcript Assays Market Size by Type (2020-2031)
7.4 Europe Fusion Transcript Assays Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Fusion Transcript Assays Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Fusion Transcript Assays Market Size by Type (2020-2031)
8.4 Asia-Pacific Fusion Transcript Assays Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Fusion Transcript Assays Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Fusion Transcript Assays Market Size by Type (2020-2031)
9.4 Central and South America Fusion Transcript Assays Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Fusion Transcript Assays Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Fusion Transcript Assays Market Size by Type (2020-2031)
10.4 Middle East and Africa Fusion Transcript Assays Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Fusion Transcript Assays Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Fusion Transcript Assays Product Features and Attributes
11.1.4 Thermo Fisher Scientific Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Fusion Transcript Assays Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Fusion Transcript Assays Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Fusion Transcript Assays Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Fusion Transcript Assays SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Corporation Information
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Fusion Transcript Assays Product Features and Attributes
11.2.4 Illumina, Inc. Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.2.5 Illumina, Inc. Fusion Transcript Assays Revenue by Product in 2024
11.2.6 Illumina, Inc. Fusion Transcript Assays Revenue by Application in 2024
11.2.7 Illumina, Inc. Fusion Transcript Assays Revenue by Geographic Area in 2024
11.2.8 Illumina, Inc. Fusion Transcript Assays SWOT Analysis
11.2.9 Illumina, Inc. Recent Developments
11.3 Merck Millipore
11.3.1 Merck Millipore Corporation Information
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Fusion Transcript Assays Product Features and Attributes
11.3.4 Merck Millipore Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.3.5 Merck Millipore Fusion Transcript Assays Revenue by Product in 2024
11.3.6 Merck Millipore Fusion Transcript Assays Revenue by Application in 2024
11.3.7 Merck Millipore Fusion Transcript Assays Revenue by Geographic Area in 2024
11.3.8 Merck Millipore Fusion Transcript Assays SWOT Analysis
11.3.9 Merck Millipore Recent Developments
11.4 Hologic Inc.
11.4.1 Hologic Inc. Corporation Information
11.4.2 Hologic Inc. Business Overview
11.4.3 Hologic Inc. Fusion Transcript Assays Product Features and Attributes
11.4.4 Hologic Inc. Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.4.5 Hologic Inc. Fusion Transcript Assays Revenue by Product in 2024
11.4.6 Hologic Inc. Fusion Transcript Assays Revenue by Application in 2024
11.4.7 Hologic Inc. Fusion Transcript Assays Revenue by Geographic Area in 2024
11.4.8 Hologic Inc. Fusion Transcript Assays SWOT Analysis
11.4.9 Hologic Inc. Recent Developments
11.5 Hologic Inc Bio-Rad Laboratories Inc.
11.5.1 Hologic Inc Bio-Rad Laboratories Inc. Corporation Information
11.5.2 Hologic Inc Bio-Rad Laboratories Inc. Business Overview
11.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Product Features and Attributes
11.5.4 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.5.5 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue by Product in 2024
11.5.6 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue by Application in 2024
11.5.7 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue by Geographic Area in 2024
11.5.8 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays SWOT Analysis
11.5.9 Hologic Inc Bio-Rad Laboratories Inc. Recent Developments
11.6 Caris Life Sciences
11.6.1 Caris Life Sciences Corporation Information
11.6.2 Caris Life Sciences Business Overview
11.6.3 Caris Life Sciences Fusion Transcript Assays Product Features and Attributes
11.6.4 Caris Life Sciences Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.6.5 Caris Life Sciences Recent Developments
11.7 SeraCare Life Sciences Inc.
11.7.1 SeraCare Life Sciences Inc. Corporation Information
11.7.2 SeraCare Life Sciences Inc. Business Overview
11.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Product Features and Attributes
11.7.4 SeraCare Life Sciences Inc. Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.7.5 SeraCare Life Sciences Inc. Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Fusion Transcript Assays Product Features and Attributes
11.8.4 QIAGEN Fusion Transcript Assays Revenue and Gross Margin (2020-2025)
11.8.5 QIAGEN Recent Developments
12 Fusion Transcript AssaysIndustry Chain Analysis
12.1 Fusion Transcript Assays Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Fusion Transcript Assays Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Fusion Transcript Assays Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Fusion Transcript Assays Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Fusion Transcript Assays Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Fusion Transcript Assays Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Fusion Transcript Assays Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fusion Transcript Assays Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Fusion Transcript Assays Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Fusion Transcript Assays Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Fusion Transcript Assays by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Transcript Assays as of 2024)
Table 11. Global Fusion Transcript Assays Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Fusion Transcript Assays Companies Headquarters
Table 13. Global Fusion Transcript Assays Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Fusion Transcript Assays Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Fusion Transcript Assays Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Fusion Transcript Assays Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Fusion Transcript Assays Revenue by Application (2026-2031) & (US$ Million)
Table 21. Fusion Transcript Assays High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Fusion Transcript Assays Growth Accelerators and Market Barriers
Table 25. North America Fusion Transcript Assays Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Fusion Transcript Assays Growth Accelerators and Market Barriers
Table 27. Europe Fusion Transcript Assays Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Fusion Transcript Assays Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Fusion Transcript Assays Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Fusion Transcript Assays Investment Opportunities and Key Challenges
Table 31. Central and South America Fusion Transcript Assays Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Fusion Transcript Assays Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Fusion Transcript Assays Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Fusion Transcript Assays SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. Illumina, Inc. Corporation Information
Table 44. Illumina, Inc. Description and Major Businesses
Table 45. Illumina, Inc. Product Features and Attributes
Table 46. Illumina, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Illumina, Inc. Revenue Proportion by Product in 2024
Table 48. Illumina, Inc. Revenue Proportion by Application in 2024
Table 49. Illumina, Inc. Revenue Proportion by Geographic Area in 2024
Table 50. Illumina, Inc. Fusion Transcript Assays SWOT Analysis
Table 51. Illumina, Inc. Recent Developments
Table 52. Merck Millipore Corporation Information
Table 53. Merck Millipore Description and Major Businesses
Table 54. Merck Millipore Product Features and Attributes
Table 55. Merck Millipore Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Merck Millipore Revenue Proportion by Product in 2024
Table 57. Merck Millipore Revenue Proportion by Application in 2024
Table 58. Merck Millipore Revenue Proportion by Geographic Area in 2024
Table 59. Merck Millipore Fusion Transcript Assays SWOT Analysis
Table 60. Merck Millipore Recent Developments
Table 61. Hologic Inc. Corporation Information
Table 62. Hologic Inc. Description and Major Businesses
Table 63. Hologic Inc. Product Features and Attributes
Table 64. Hologic Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Hologic Inc. Revenue Proportion by Product in 2024
Table 66. Hologic Inc. Revenue Proportion by Application in 2024
Table 67. Hologic Inc. Revenue Proportion by Geographic Area in 2024
Table 68. Hologic Inc. Fusion Transcript Assays SWOT Analysis
Table 69. Hologic Inc. Recent Developments
Table 70. Hologic Inc Bio-Rad Laboratories Inc. Corporation Information
Table 71. Hologic Inc Bio-Rad Laboratories Inc. Description and Major Businesses
Table 72. Hologic Inc Bio-Rad Laboratories Inc. Product Features and Attributes
Table 73. Hologic Inc Bio-Rad Laboratories Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Hologic Inc Bio-Rad Laboratories Inc. Revenue Proportion by Product in 2024
Table 75. Hologic Inc Bio-Rad Laboratories Inc. Revenue Proportion by Application in 2024
Table 76. Hologic Inc Bio-Rad Laboratories Inc. Revenue Proportion by Geographic Area in 2024
Table 77. Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays SWOT Analysis
Table 78. Hologic Inc Bio-Rad Laboratories Inc. Recent Developments
Table 79. Caris Life Sciences Corporation Information
Table 80. Caris Life Sciences Description and Major Businesses
Table 81. Caris Life Sciences Product Features and Attributes
Table 82. Caris Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Caris Life Sciences Recent Developments
Table 84. SeraCare Life Sciences Inc. Corporation Information
Table 85. SeraCare Life Sciences Inc. Description and Major Businesses
Table 86. SeraCare Life Sciences Inc. Product Features and Attributes
Table 87. SeraCare Life Sciences Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. SeraCare Life Sciences Inc. Recent Developments
Table 89. QIAGEN Corporation Information
Table 90. QIAGEN Description and Major Businesses
Table 91. QIAGEN Product Features and Attributes
Table 92. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. QIAGEN Recent Developments
Table 94. Raw Materials Key Suppliers
Table 95. Distributors List
Table 96. Market Trends and Market Evolution
Table 97. Market Drivers and Opportunities
Table 98. Market Challenges, Risks, and Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Fusion Transcript Assays Product Picture
Figure 2. Global Fusion Transcript Assays Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Fusion Transcript Kits Product Picture
Figure 4. PCR Devices Product Picture
Figure 5. Global Fusion Transcript Assays Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Cancer Research Center
Figure 8. Diagnostic Laboratory
Figure 9. Others
Figure 10. Fusion Transcript Assays Report Years Considered
Figure 11. Global Fusion Transcript Assays Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 13. Global Fusion Transcript Assays Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Fusion Transcript Assays Revenue Market Share by Region (2020-2031)
Figure 15. Global Fusion Transcript Assays Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Fusion Transcript Kits Revenue Market Share by Player in 2024
Figure 18. PCR Devices Revenue Market Share by Player in 2024
Figure 19. Global Fusion Transcript Assays Revenue Market Share by Type (2020-2031)
Figure 20. Global Fusion Transcript Assays Revenue Market Share by Application (2020-2031)
Figure 21. North America Fusion Transcript Assays Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Fusion Transcript Assays Revenue (US$ Million) in 2024
Figure 23. North America Fusion Transcript Assays Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Fusion Transcript Assays Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Fusion Transcript Assays Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Fusion Transcript Assays Revenue (US$ Million) in 2024
Figure 30. Europe Fusion Transcript Assays Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Fusion Transcript Assays Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 33. France Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Fusion Transcript Assays Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Fusion Transcript Assays Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Fusion Transcript Assays Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Fusion Transcript Assays Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 45. India Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Fusion Transcript Assays Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Fusion Transcript Assays Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Fusion Transcript Assays Revenue (US$ Million) in 2024
Figure 53. Central and South America Fusion Transcript Assays Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Fusion Transcript Assays Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Fusion Transcript Assays Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Fusion Transcript Assays Revenue (US$ Million) in 2024
Figure 59. South America Fusion Transcript Assays Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Fusion Transcript Assays Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Fusion Transcript Assays Revenue (2020-2025) & (US$ Million)
Figure 65. Fusion Transcript Assays Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Fusion Transcript Assays market size from 2025 to 2031?
The annual compound growth rate of the global Fusion Transcript Assays market is 3.6% 2025 to 2031.
What was the global market size of Fusion Transcript Assays in 2031?
What was the global market size of Fusion Transcript Assays in 2025?
Which companies rank high in the global Fusion Transcript Assays market?
Which region is expected to have the highest market share?
Related Reports
Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 106
USD 3950.00
(Single User License)
Global Fusion Transcript Assays Market Research Report 2026
The global Fusion Transcript Assays market was valued at US$ 96 million in 2025 and is anticipated to reach US$ 123 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 107
USD 2900.00
(Single User License)
Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fusion Transcript Assays was estimated to be worth US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 100
USD 3950.00
(Single User License)
Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-01-13
Pages: 73
USD 2900.00
(Single User License)
Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 106
USD 3950.00 (Single User License)Global Fusion Transcript Assays Market Research Report 2026
The global Fusion Transcript Assays market was valued at US$ 96 million in 2025 and is anticipated to reach US$ 123 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 107
USD 2900.00 (Single User License)Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fusion Transcript Assays was estimated to be worth US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 100
USD 3950.00 (Single User License)Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-01-13
Pages: 73
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now